English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90429/105609 (86%)
Visitors : 10321842      Online Users : 416
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/108320

    Title: Drug repurposing and therapeutic anti-microRNA predictions in oxidized low-density lipoprotein-induced the proliferation of vascular smooth muscle cell associated diseases
    Authors: Shun-Tsung C;Shun-Tsung Chen;Chien-Hung H;Chien-Hung Huang;郭集慶;Victor C. Kok;Jin-Shuei Ci;Jin-Shuei Ciou;蔡進發;JEFFREY J. P. TSAI;Nilubon Kuru;Nilubon Kurubanjerdjit;Chi-Ying F H;Chi-Ying F Huang;吳家樂;Ng, Ka-Lok
    Contributors: 生物資訊與醫學工程學系
    Date: 2017-02
    Issue Date: 2017-11-03 14:09:13 (UTC+8)
    Abstract: Drug repurposing is a new method for disease treatments, which accelerates the identification of new uses for existing drugs with minimal side effects for patients. MicroRNA-based therapeutics are a class of drugs that have been used in gene therapy following the FDA’s approval of the first anti-sense therapy. This study examines the effects of oxLDL on vascular smooth muscle cells (VSMCs) and identifies potential drugs and antimiRs for treating VSMC-associated diseases. The Connectivity Map (cMap) database is utilized to identify potential new uses of existing drugs. The success of the identifications was supported by MTT assay, clonogenic assay and clinical trial data. Specifically, 37 drugs, some of which are undergoing clinical trials, were identified. Three of the identified drugs exhibit IC50 activities. Among the 37 drugs’ targets, three differentially expressed genes (DEGs) are identified as drug targets by using both the DrugBank and the NCBI PubChem Compound databases. Also, one DEG, DNMT1, which is regulated by 17 miRNAs, where these miRNAs are potential targets for developing antimiR-based miRNA therapy, is found.

    Read More: http://www.worldscientific.com/doi/abs/10.1142/S0219720016500438?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
    Relation: Journal of Bioinformatics and Computational Biology
    Appears in Collections:[生物資訊與醫學工程學系 ] 期刊論文

    Files in This Item:

    File SizeFormat

    All items in ASIAIR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback